Streetbeat News

Regulatory

SPY

Federal Reserve's Cook did not comment on monetary policy or economic outlook in his prepared remarks to an AI conference, according to Reuters.

Portfolio Pulse from Benzinga Newsdesk

September 22, 2023 | 12:51 pm

INTC

QCOM

SSNLF

TSM

The Biden administration has set guidelines restricting the growth of semiconductor companies in China that receive federal funds for establishing facilities in the U.S. The Chips Program Office will restrict companies from significantly increasing their production or expanding their manufacturing footprint in China. The growth limits are set at 5% for advanced chips and 10% for older technologies. Companies like Intel Corp, Taiwan Semiconductor Manufacturing Co, and Samsung Electronics Co will likely receive federal incentives for new U.S.-based facilities.

Portfolio Pulse from Anusuya Lahiri

September 22, 2023 | 12:43 pm

LLY

The U.S. FDA has approved Jardiance, a drug developed by Eli Lilly and Company (LLY), for the treatment of adults with Chronic Kidney Disease (CKD). The approval is based on the EMPA-KIDNEY phase III trial, which showed that Jardiance significantly reduced the risk of kidney disease progression and cardiovascular death in adults with CKD.

Portfolio Pulse from Benzinga Newsdesk

September 22, 2023 | 12:36 pm

EWW

UNG

USO

A U.S. judge in Louisiana has granted a preliminary injunction and ordered an oil and gas lease sale in the Gulf of Mexico by September 30, according to a court document cited by Reuters.

Portfolio Pulse from Benzinga Newsdesk

September 22, 2023 | 12:18 pm

INTC

Intel has been fined $400 million by the EU in an antitrust case related to actions taken between 2002 and 2006. The case, which accuses Intel of illegally excluding rivals from the market, was reopened after an initial fine of 1.06 billion euros in 2009 was dismissed last year. The EU watchdog has accused Intel of paying HP, Acer, and Lenovo to halt or delay rival products.

Portfolio Pulse from Benzinga Newsdesk

September 22, 2023 | 12:17 pm

ALZN

Alzamend Neuro has been granted an extension by the Nasdaq panel to regain compliance with the minimum bid price continued listing requirement.

Portfolio Pulse from Benzinga Newsdesk

September 22, 2023 | 12:13 pm

MRDB

MariaDB Corporation has received a notice from the New York Stock Exchange (NYSE) regarding non-compliance with continued listing standards. The specifics of the non-compliance were not detailed in the news.

Portfolio Pulse from Benzinga Newsdesk

September 22, 2023 | 12:07 pm

EUDA

EUDA Health Holdings Limited has regained compliance with Nasdaq Capital Market's continued listing requirements.

Portfolio Pulse from Benzinga Newsdesk

September 22, 2023 | 12:01 pm

EVH

The U.S. Department of Health and Human Services (HHS) has instructed 30 states to pause disenrollments from their Medicaid and Children's Health Insurance Program (CHIP) programs due to a technical glitch. The glitch, which was discovered in August, has led to the loss of coverage for nearly 500,000 children and other individuals. The pause in disenrollment is seen as a modest positive, likely reducing the number of disenrolled beneficiaries. This development may benefit Managed Medicaid organizations and Evolent Health Inc (NYSE:EVH).

Portfolio Pulse from Vandana Singh

September 22, 2023 | 11:56 am

AMGN

BAYRY

NVS

Pharmaceutical companies are using artificial intelligence (AI) to expedite the process of clinical trials, potentially saving time and money. Companies like Amgen Inc, Bayer AG, and Novartis AG are using AI to analyze large amounts of data. Amgen's AI tool, ATOMIC, has proven to expedite the trial enrollment process, with the company aiming to use it for most of its studies by 2024. However, concerns about potential inaccuracies when comparing non-randomized data sets remain.

Portfolio Pulse from Vandana Singh

September 22, 2023 | 11:49 am